Market Overview

Peripheral artery disease (PAD) is a blood circulation disorder due to buildup of plaque in the arteries that supply blood to the peripheral organs such as legs, arms, and others organs apart from brain and heart. Patients with PAD are at the higher risk for major atherothrombotic events such as stroke and myocardial infarction.

Peripheral artery revascularization is minimally invasive treatment to improve blood circulation with less pain and scarring, and faster recovery time. Increasing prevalence of lifestyle diseases such as obesity and diabetes associated with high cholesterol level has led to peripheral artery disease which in turn influences the development of peripheral artery revascularization market.

Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1004

Peripheral Artery Revascularization Market: Regional Outlook

Approximately, more than 10% people with peripheral artery disease live in the U.S. Nearly, 70% of total population affected with peripheral artery disease live in low to middle income regions. Hence, Asia-Pacific and Middle East peripheral artery revascularization market is expected to grow significantly. Regions like North America and Europe are witnessing steady growth in prevalence of peripheral artery disease which in turn leads to growth of the peripheral artery revascularization market.

Peripheral Artery Revascularization Market: Key Players

Some of the global key players operating in peripheral artery revascularization market are

• Boston Scientific Corporation
• Abbott Laboratories
• AngioDynamics, Inc.
• Cook Medical
• Cardinal Health, Inc.
• C. R. Bard, Inc.
• The Spectranetics Corporation